PPM1M and cancer: We continued to investigate the expression levels of PPM1M in a variety of tumors at different stages, and the results demonstrated remarkable differences in KIRC, KIRP, LUAD, and TGCT, with the expression levels of PPM1M in patients with cancer (stages I–II).